Discovery of 4‑Hydroxyquinazoline Derivatives as Small Molecular BET/PARP1 Inhibitors That Induce Defective Homologous Recombination and Lead to Synthetic Lethality for Triple-Negative Breast Cancer Therapy.

Details

Language :

English

ISSN :

00222623

Volume :

65

Issue :

9

Database :

Supplemental Index

Journal :

Journal of Medicinal Chemistry

Publication Type :

Academic Journal

Accession number :

156858053

Full Text :

https://doi.org/10.1021/acs.jmedchem.2c00135